Stryker (SYK) Competitors

Stryker (NYSE:SYK) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, community ranking, institutional ownership, dividends, profitability and earnings.

Which has more risk & volatility, SYK or ABT?

Stryker has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500.

Which has stronger earnings & valuation, SYK or ABT?

Abbott Laboratories has higher revenue and earnings than Stryker. Abbott Laboratories is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stryker	$23.22B	6.22	$2.99B	$7.40	51.11
Abbott Laboratories	$42.34B	5.42	$13.40B	$7.71	17.11

Do institutionals and insiders have more ownership in SYK or ABT?

77.1% of Stryker shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 5.9% of Stryker shares are owned by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the media prefer SYK or ABT?

In the previous week, Abbott Laboratories had 1 more articles in the media than Stryker. MarketBeat recorded 43 mentions for Abbott Laboratories and 42 mentions for Stryker. Abbott Laboratories' average media sentiment score of 1.37 beat Stryker's score of 1.16 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stryker	30 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Abbott Laboratories	32 Very Positive mention(s)	6 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Is SYK or ABT a better dividend stock?

Stryker pays an annual dividend of $3.36 per share and has a dividend yield of 0.9%. Abbott Laboratories pays an annual dividend of $2.36 per share and has a dividend yield of 1.8%. Stryker pays out 45.4% of its earnings in the form of a dividend. Abbott Laboratories pays out 30.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Stryker has increased its dividend for 32 consecutive years and Abbott Laboratories has increased its dividend for 54 consecutive years. Abbott Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Do analysts prefer SYK or ABT?

Stryker currently has a consensus target price of $427.05, suggesting a potential upside of 12.91%. Abbott Laboratories has a consensus target price of $142.59, suggesting a potential upside of 8.07%. Given Stryker's higher possible upside, equities analysts clearly believe Stryker is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stryker	0 Sell rating(s)	4 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.79
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.84

Is SYK or ABT more profitable?

Abbott Laboratories has a net margin of 31.95% compared to Stryker's net margin of 13.25%. Stryker's return on equity of 23.58% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stryker	13.25%	23.58%	11.37%
Abbott Laboratories	31.95%	20.74%	11.19%

Does the MarketBeat Community prefer SYK or ABT?

Abbott Laboratories received 15 more outperform votes than Stryker when rated by MarketBeat users. Likewise, 70.00% of users gave Abbott Laboratories an outperform vote while only 64.44% of users gave Stryker an outperform vote.

Company	Underperform	Outperform
Stryker	Outperform Votes 937 64.44%	Underperform Votes 517 35.56%
Abbott Laboratories	Outperform Votes 952 70.00%	Underperform Votes 408 30.00%

Summary

Abbott Laboratories beats Stryker on 13 of the 22 factors compared between the two stocks.